News

New pancreatic cancer drug halts tumour growth in 90% of patients

Financial Times

Successful small-scale trial raises hopes that new approach could be extended to other types of the disease

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.